What Do We Really Mean by Personalized Medicine?
Dr. Igor Koman, Founder and CEO of Smartomica
Having been involved in the field of personalized medicine for over two decades, I have rarely paused to consider what people actually mean when they use the term. For a long time, through the early 2000s, the 2010s, and even more recently, it was generally accepted that “personalized medicine” referred primarily to the identification of certain genetic alterations associated with clinical conditions. For reasons that were never fully clear to me, this narrow understanding became the dominant definition...
Read moreFrom Clinical Logic to Executable Intelligence: The Smartomica Model
Dr. Igor Koman, Founder and CEO of Smartomica
As artificial intelligence (AI) advances in healthcare, a structural gap remains between algorithmic output and the real-world reasoning of physicians. Most AI tools today are correlation-based systems, detached from the hypothesis-driven, contextual, and explainable nature of clinical decision-making...
Read moreRethinking Headaches: A Gateway to Personalized Longevity Care
Dr. Igor Koman, Founder and CEO of Smartomica
In the evolving field of preventive and longevity medicine, early detection is everything. At Smartomica, we are developing a new class of personalized intervention platform, designed not just to alleviate symptoms, but to identify and reverse the earliest signs of systemic dysfunction: the silent biological shifts that precede chronic disease and accelerate aging...
Read more
